Empagliflozin: a new treatment option for patients with type 2 diabetes mellitus.
G.E. Dailey
págs. 519-536
Filgrastim for the treatment of hematopoietic acute radiation syndrome.
A.M. Farese, T.J. MacVittie
págs. 537-548
Talimogene laherparepvec (T-VEC) as cancer immunotherapy.
F.J. Kohlhapp, A. Zloza, H.L. Kaufman
págs. 549-558
A report from the World Conference on Lung Cancer (September 6-9, 2015 – Denver, Colorado, USA).
Xavier Rabasseda
págs. 559-568
Cancer Vaccines – SMi's Fourth Annual Conference (September 16-17, 2015 – London, UK).
B. Searle
págs. 569-573
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: